- Published on
Toxicology – Trazodone and Nefazodone
Description
Trazodone and nefazodone are atypical antidepressant medications.
Forms and Uses
Trazodone
Trazodone, historically marketed as Desyrel, is used for depression.
The adult dosage ranges from approximately 150–600 mg/day orally in divided doses.
Treatment is usually started at about 150 mg/day, with the dose increased by approximately 50 mg/day every 3–4 days as needed.
It is not recommended for pediatric use.
Nefazodone
Nefazodone, historically marketed as Serzone, is also used for depression.
The adult dosage ranges from approximately 200–600 mg/day orally in divided doses.
Treatment is generally started at 200 mg/day, with increases of approximately 100–200 mg/day at intervals of at least one week.
It is not recommended for children.
In elderly or debilitated patients, therapy should be started more cautiously, historically around 100 mg/day, with slower dose escalation.
Toxic Dose
In adults, an acute trazodone ingestion of approximately 2–3 g may produce significant toxicity, including respiratory depression.
There is less information regarding nefazodone overdose, but its toxicity is expected to resemble that of trazodone.
Pathophysiology
The therapeutic effects of trazodone and nefazodone are related mainly to effects on serotonin receptors, particularly 5-HT2 receptors.
They also possess α-adrenergic blocking activity and weaker α2-receptor effects.
Their effects on cardiac conduction resemble those of tricyclic antidepressants qualitatively, but are generally much less severe.
Anticholinergic effects are minimal.
No evidence of carcinogenicity has been reported.
Epidemiology
Overdose with these medications is relatively common.
Most isolated exposures result in mild to moderate toxicity.
Fatalities are more likely after massive ingestion or when other drugs are taken at the same time.
Causes
Overdose is usually intentional.
In very young children, unexplained exposure may raise concern for neglect or abuse.
In older children, adolescents, and adults, intentional self-poisoning should be considered when appropriate.
Drug and Disease Interactions
Trazodone and nefazodone can have additive effects with other central nervous system depressants, including:
Ethanol, benzodiazepines, barbiturates, and opioid drugs.
Serotonin syndrome may occur when they are combined with:
Monoamine oxidase inhibitors
or
Other serotonin-enhancing medications.
Both increased and decreased prothrombin times have been reported when these medications are taken with warfarin.
They may also alter concentrations of drugs metabolized through the cytochrome P450 system, including historically noted medications such as:
Astemizole, alprazolam, and triazolam.
Pregnancy and Lactation
Experience with trazodone or nefazodone overdose during pregnancy is limited.
The historical FDA classification was Pregnancy Category C, reflecting adverse fetal effects in animal studies with insufficient controlled human data.
Differential Diagnosis
Other toxic causes of CNS depression include:
Other serotonergic antidepressants, tricyclic antidepressants, ethanol, benzodiazepines, barbiturates, and opioids.
Non-toxicologic causes include:
Electrolyte disorders, hypoglycemia, hypoxia, infection, intracranial hemorrhage, and stroke.
Clinical Features
The main clinical effects of concern are:
CNS depression + lethargy + ataxia + myoclonus
Coma may occur after a large ingestion.
Vital Signs
Possible abnormalities include:
Hyperthermia, particularly with serotonin syndrome.
Hypotension, which is relatively common.
Hypertension, which is uncommon.
Bradycardia
and
Respiratory depression.
HEENT
Rare manifestations include:
Tinnitus, blurred vision, and dry mouth.
Cardiovascular Effects
Bradycardia may occur.
Transient first-degree atrioventricular block has also been reported.
Rarely, patients may develop:
QTc prolongation
and
Torsade de pointes.
Pulmonary Effects
Severe overdose can result in respiratory depression.
Gastrointestinal Effects
Nausea and vomiting may occur.
Hepatic Effects
Elevated liver enzymes have occasionally been reported during therapeutic use.
Hematologic Effects
Leukopenia has been reported during treatment.
Fluids and Electrolytes
Hyponatremia may occur in overdose.
Peripheral edema has been reported during therapeutic use.
Musculoskeletal Effects
Muscle weakness may occur.
Rhabdomyolysis can develop when toxicity is complicated by serotonin syndrome.
Neurologic Effects
Neurologic manifestations may include:
Dizziness
CNS depression
Ataxia
Seizures
and
Serotonin syndrome.
Mania may occur during therapeutic treatment.
After severe overdose, coma may be prolonged.
Urologic Effects
Priapism is an important complication of trazodone exposure.
It has been reported both during therapy and after overdose.
Laboratory Evaluation
Minimally symptomatic patients may not require extensive testing.
In symptomatic patients, useful studies include:
Serum electrolytes
Glucose
BUN
Creatinine
and other tests needed to evaluate altered mental status.
ECG
An ECG should be obtained in significant overdose to assess for:
Bradycardia
AV conduction abnormalities
QT prolongation
or
Dysrhythmias.
Screening for Coingestants
In an overdose setting, acetaminophen and salicylate concentrations may be obtained to identify occult coingestion.
Additional Evaluation of Altered Mental Status
When CNS depression is unexplained or unusually severe, additional evaluation may include:
Head CT
Lumbar puncture
Cultures
Toxicology studies
and other investigations directed by the clinical presentation.
Drug Levels
Quantitative trazodone or nefazodone serum concentrations are not generally useful for clinical management.
Treatment
Treatment is mainly supportive.
The priorities are:
Airway management + respiratory support + cardiovascular stabilization
The amount taken, timing of exposure, and possible coingestants should be determined whenever possible.
When to Seek Toxicology Assistance
Poison-center or toxicology consultation is appropriate when:
Altered mental status
Dysrhythmia
or other severe toxicity develops.
Consultation is also appropriate when the clinical picture is inconsistent with the reported exposure or when coingestants or underlying disease complicate management.
Referral to a Health-Care Facility
Patients should be medically evaluated when:
Intentional overdose is suspected
Symptoms develop
The history is unreliable
or
Significant coingestants or medical conditions are present.
Admission
Hospital admission is appropriate for patients with:
Persistent CNS abnormalities
Hypotension
Dysrhythmias
or
ECG abnormalities.
Decontamination – Out of Hospital
Vomiting should not be induced.
Decontamination – In Hospital
The historical approach included gastric lavage after a large recent ingestion or when severe toxicity was already present.
A single dose of activated charcoal was also recommended after a substantial recent ingestion.
Antidote
There is no specific antidote for trazodone or nefazodone poisoning.
Treatment is supportive.
Torsade de Pointes
If torsade de pointes develops, treatment may include:
Intravenous magnesium
Isoproterenol
and
Overdrive cardiac pacing.
Hypotension
Hypotension should initially be treated with isotonic intravenous fluids, historically around:
10–20 mL/kg
The older approach also included Trendelenburg positioning.
If hypotension persists, a vasopressor such as dopamine may be used.
For refractory hypotension, norepinephrine is recommended.
Seizures
For seizures, airway protection should be ensured first.
Benzodiazepines are used for initial seizure control.
If seizures persist or recur, another anticonvulsant such as phenobarbital may be added.
Serotonin Syndrome
Serotonin syndrome is treated with:
Temperature control
Muscle relaxation
Endotracheal intubation when required
and
General supportive care.
Priapism
Priapism requires urgent treatment.
Management may include:
Intracavernosal norepinephrine
or
Surgical intervention
depending on severity.
Immediate urologic consultation is recommended.
Delay in treatment may result in permanent erectile dysfunction.
Patient Monitoring
Symptomatic patients should receive continuous monitoring of:
Respiratory function
Cardiac rhythm
and
Blood pressure.
Mental status should also be followed closely for progression or improvement of CNS depression.
Expected Course and Prognosis
Most patients who take only trazodone or nefazodone recover completely.
Patients with significant CNS depression may require approximately 24–48 hours for full recovery.
Vomiting during CNS depression creates a risk of aspiration.
Potentially life-threatening complications include:
Seizures
Cardiac dysrhythmias
and
Serotonin syndrome.
Discharge From the Emergency Department
An asymptomatic patient may be considered for discharge after approximately 6 hours of observation, provided no toxicity develops and psychiatric assessment has been completed when appropriate.
Discharge From Hospital
Hospitalized patients may be discharged after:
CNS depression resolves
Hemodynamic and cardiac abnormalities resolve
and
Appropriate psychiatric assessment is completed when indicated.
Important Pitfalls
Failure to provide adequate early airway management in a patient with significant CNS depression may lead to:
Aspiration
or
Hypoxic injury.
Several antiarrhythmic agents that can further prolong the QT interval are generally undesirable in patients with significant QT prolongation.
Historically listed examples include:
Quinidine
Procainamide
Disopyramide
Isoproterenol
Amiodarone
and other QT-prolonging medications.
Priapism must be recognized and treated promptly.
Delayed treatment may lead to permanent erectile dysfunction.
High-Yield Toxicology Pearls
Trazodone and nefazodone are atypical serotonergic antidepressants with α-adrenergic blocking effects.
The principal overdose syndrome is:
CNS depression + ataxia + hypotension + bradycardia ± respiratory depression
Large trazodone ingestions of approximately 2–3 g may produce significant respiratory depression.
Cardiac effects may include:
First-degree AV block
QT prolongation
and, rarely:
Torsade de pointes
Serotonin syndrome may occur when these drugs are combined with other serotonergic medications.
Seizures should initially be treated with:
Benzodiazepines
Persistent hypotension may require intravenous fluids and vasopressor support.
There is:
No specific antidote.
Trazodone is particularly associated with:
Priapism
which requires urgent urologic assessment.
The most important bedside warning is:
In trazodone overdose, persistent CNS depression, hypotension, QT abnormalities, or priapism should never be dismissed as minor effects.